Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey
Yeoungjee Cho, Allison Tong(The University of Sydney), Albert Ong(University of Sheffield), Tess Harris(Polycystic Kidney Disease Foundation), Curie Ahn(Seoul National University), Bénédicte Sautenet(Université de Tours), Jonathan C. Craig(Flinders University), Gopala K. Rangan(Westmead Hospital), Talia Gutman(The University of Sydney), David W. Johnson(Hennepin County), York Pei(University Health Network), Armando Teixeira‐Pinto(The University of Sydney), Helen Coolican(Kidney Health Australia), Reem A. Mustafa(University of Kansas Medical Center), Vicente E. Torres(Mayo Clinic in Arizona), Hyunjin Ryu(The University of Texas MD Anderson Cancer Center), Andrea K. Viecelli(The University of Queensland), Charlotte Logeman(The University of Sydney), Martin Howell(UNSW Sydney), Htay Htay(Singapore General Hospital), Ronald D. Perrone(Tufts Medical Center), Angela Ju(The University of Sydney), Annie-Claire Nadeau-Fredette, Michel Chonchol(University of Colorado Anschutz Medical Campus), Juliana Tze‐Wah Kao(Fu Jen Catholic University), Ron T. Gansevoort(University Medical Center Groningen), Arlene B. Chapman(Emory University), Karine Manera(The University of Sydney)
Cited by 36
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
|Annals of Internal Medicine|2003|4.6k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k